Status: Not yet recruiting
The German National CRS Registry (GenreCRS): Clinical Evaluation of the New European Academy for Allergy and Clinical Immunology (EAACI) Criteria for CRSwNP Disease Control, Remission and Cure in a Real-World Evidence Study Approach
The objective of the study is to establish a registry of patients diagnosed with Chronic Rhinosinusitis with and without Nasal Polyps (CRSwNP/CRSsNP) to collect comprehensive longitudinal real-world evidence from specialised treatment centres in Germany. The primary analysis will concentrate on the treatment efficacy and safety of biologic drugs with a focus on defining disease Control, Remission, and Cure as well as to validate the corresponding clinical evaluation criteria.
Participants needed: 500
Trial details
Age: 12+Biological sex: AllType: ObservationalSponsor: Ärzteverband Deutscher Allergologen e.V.Updated: Jun 4, 2025Duration: 1 Year
Eligibility criteria
Patients above the age of 12 years [+2]
Patients below the age of 12 years at initiation [+1]